Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $14.02 in the prior trading day, Mind Medicine Inc (NASDAQ: MNMD) closed at $13.43, down -4.21%. In other words, the price has decreased by -$4.21 from its previous closing price. On the day, 1.43 million shares were traded. MNMD stock price reached its highest trading level at $14.17 during the session, while it also had its lowest trading level at $13.252.
Ratios:
Our goal is to gain a better understanding of MNMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.30 and its Current Ratio is at 3.30. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.31.
Upgrades & Downgrades
In the most recent recommendation for this company, Needham on October 13, 2025, initiated with a Buy rating and assigned the stock a target price of $28.
On January 28, 2025, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $23.Evercore ISI initiated its Outperform rating on January 28, 2025, with a $23 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 25 ’25 when Sullivan Mark sold 11,278 shares for $9.77 per share. The transaction valued at 110,186 led to the insider holds 293,852 shares of the business.
Barrow Robert sold 25,797 shares of MNMD for $252,037 on Sep 25 ’25. The Chief Executive Officer now owns 804,268 shares after completing the transaction at $9.77 per share. On Sep 25 ’25, another insider, Karlin Daniel, who serves as the Chief Medical Officer of the company, sold 7,704 shares for $9.77 each. As a result, the insider received 75,268 and left with 430,625 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 1305653760 and an Enterprise Value of 1154894592.
Stock Price History:
The Beta on a monthly basis for MNMD is 2.63, which has changed by 0.9634503 over the last 52 weeks, in comparison to a change of 0.16098404 over the same period for the S&P500. Over the past 52 weeks, MNMD has reached a high of $14.43, while it has fallen to a 52-week low of $4.70. The 50-Day Moving Average of the stock is 9.04%, while the 200-Day Moving Average is calculated to be 46.41%.
Shares Statistics:
The stock has traded on average 2.05M shares per day over the past 3-months and 2383200 shares per day over the last 10 days, according to various share statistics. A total of 76.77M shares are outstanding, with a floating share count of 73.33M. Insiders hold about 2.94% of the company’s shares, while institutions hold 51.91% stake in the company. Shares short for MNMD as of 1765756800 were 12612667 with a Short Ratio of 6.17, compared to 1763078400 on 12287817. Therefore, it implies a Short% of Shares Outstanding of 12612667 and a Short% of Float of 12.879999999999999.
Earnings Estimates
A comprehensive evaluation of Mind Medicine Inc (MNMD) is underway, with the input of 8.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.46, with high estimates of -$0.43 and low estimates of -$0.49.
Analysts are recommending an EPS of between -$1.76 and -$2.31 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$1.77, with 10.0 analysts recommending between -$1.0 and -$2.08.
